For decades, the fight against malaria in Africa has operated under a resilient yet fragile status quo. While progress has been made, the complexity of the landscape is shifting. We are currently facing a dual-front battle: the looming catastrophe of antimalarial drug resistance and a persistent innovation gap that leaves out most vulnerable patients behind.

Moving from “disease control” to true eradication requires a clear, actionable shift in how we approach innovation, distribution, and partnership.

Strategic gaps and solutions in current malaria management in Africa:

The path forward must be inclusive, yet today’s landscape is defined by significant deficits:

1. Therapeutic Resilience:

• Anti-Microbial Resistance (AMR): Heavy reliance on Artemisinin-based Combination Therapies (ACTs) has created a strategic vulnerability with emerging anti-microbial resistance
• Innovation for new therapeutic class: Invest in innovation for a new generation of therapeutic class that bypasses the existing resistance mechanisms

2. Paediatric Treatment:

• Inadequate infant formulations: Current treatment protocols of malaria lack suitable formulations for vulnerable patients like infants under six months or those weighing less than 5kg, forcing clinicians to adapt adult doses to meet the requirements
• Prioritized research & development: Dedicated R&D to engineer formulations with age-specific and weight-banded doses specifically designed for infants and pediatric patients

3. Diagnostic Gaps:

• Lack of proper diagnosis: In remote areas of Africa, the lack of high sensitivity Rapid Diagnostic Tests (RDT) leads to presumptive treatment without proper diagnosis leading to drug resistance
• Diagnostic inventories and staff training: Equip laboratories with functional microscopes, Rapid Diagnostic Tests (RDT) inventories and train staff to dispense anti malarial treatment after confirmed diagnosis discouraging presumptive treatment

4. Supply Chain Logistics:

• Fragmented distribution infrastructure: Rural regions of Africa face a distribution bottleneck due to fragmented infrastructure, seasonal weather disruptions, poor road conditions and central bureaucratic delays creating a bottleneck for access to life saving medicines
• Decentralize distribution networks: Establish autonomous district-level supply chain units to allow local responders to react to outbreaks in real time

From Financial Dependency to Sustainability:

The current financial architecture of malaria control is heavily dependent on external donors and is inherently unstable leaving national programs vulnerable to shifts in global political priorities or funding cycles. Furthermore, decisions are often made at a national level based on donor-approved plans. Regional health authorities lack the flexibility to respond to local micro-epidemics or specific provincial needs.

To shift this burden from “donor projects” to sustainable national infrastructure, National governments must integrate malaria treatment into National Health Insurance (NHI) schemes transitioning malaria care from a vertical, donor-funded silo into a horizontal, integrated part of the national health system.

The future lies in dynamic partnerships between Governments, NGOs, the Private Sector, and International Bodies.

• Governments should move from being passive recipients of aid to active regulators who ensure donor agendas align with national priorities.
• NGOs should focus on bridging the gap where government infrastructure ends, specializing in community-level distribution and public awareness.
• The Private Sector can provide critical funding for vector control and employee coverage, relieving pressure on the public system.
• International Bodies must shift their role from “funders” to “enablers,” focusing on technology transfer and building local manufacturing capacity so that Africa can produce the medicines it needs.

The complexity of the malaria crisis is immense. It requires governments, NGOs and donors to move beyond the comfort of established protocols and embrace a more integrated, innovative, and self-sustaining model.